- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 1, 2026 | 121.92M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 129M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 125M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $126M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $11M |
| Capex | Q1 2026 · Mar 31, 2026 | $20M |
| Capex | Q1 2026 · Mar 31, 2025 | $5M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$9M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $75M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $486M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $290M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $0 |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $29M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $175M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $195M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$144M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$98M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$285M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$337M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $779M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $914M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.34B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.3B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $667M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $652M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.2B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.2B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.69 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.38 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.71 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.38 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $124M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $133M |
| Net Income | Q1 2026 · Mar 31, 2026 | $89M |
| Net Income | Q1 2026 · Mar 31, 2025 | $47M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $137M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $66M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $277M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $221M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $40M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $44M |
| Revenue | Q1 2026 · Mar 31, 2026 | $317M |
| Revenue | Q1 2026 · Mar 31, 2025 | $266M |